0000914121-05-000628.txt : 20120622
0000914121-05-000628.hdr.sgml : 20120622
20050321110414
ACCESSION NUMBER: 0000914121-05-000628
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050321
DATE AS OF CHANGE: 20050321
GROUP MEMBERS: RICHARD C. PERRY
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN LABORATORIES INC
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-10728
FILM NUMBER: 05693351
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRY CORP
CENTRAL INDEX KEY: 0000919085
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: 599 LEXINGTON AVE
STREET 2: 36TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2125834100
MAIL ADDRESS:
STREET 1: 599 LEXINGTON
STREET 2: 36TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
SC 13D/A
1
pe707685-13da1.txt
SCHEDULE 13D AMENDMENT NO. 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Amendment No. 1
Under the Securities Exchange Act of 1934
Mylan Laboratories, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.50
--------------------------------------------------------------------------------
(Title of Class of Securities)
628530107
--------------------------------------------------------------------------------
(CUSIP Number)
George Travers
Perry Corp.
599 Lexington Avenue
New York, NY 10022
(212) 583-4000
--------------------------------------------------------------------------------
(Name, Address, and Telephone Number of
Person Authorized to Receive Notices and Communications)
March 18, 2005
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 3d-1(f), or 13d-1(g), check the
following box |_|.
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule 13d-7
for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Perry Corp.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 26,626,300
SHARES --------------------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY
EACH NONE
REPORTING --------------------------------------------------------------
PERSON 9. SOLE DISPOSITIVE POWER
WITH
26,626,300
--------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
NONE
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
26,626,300
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.89%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
IA, CO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
-2-
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Richard C. Perry
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 26,626,300(all shares beneficially owned by Perry Corp.
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING NONE
PERSON --------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
26,626,300 (all shares beneficially owned by Perry Corp.)
--------------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
NONE
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
26,626,300
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.89%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
IN, HC
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
-3-
INTRODUCTION
This Amendment No. 1 (this "Amendment") relates to the Schedule 13D filed
on behalf of Perry Corp. and Richard C. Perry (collectively, the "Reporting
Persons") with the Securities and Exchange Commission on November 29, 2004 (the
"Schedule 13D"), relating to common shares, $.50 par value ("Common Stock"), of
Mylan Laboratories, Inc. (the "Company"). The Common Stock beneficially owned by
the Reporting Persons is hereinafter referred to as the "Shares."
Items 4 and 5 of the Schedule 13D are amended and supplemented as follows:
ITEM 4. PURPOSE OF TRANSACTION:
On February 27, 2005, the Company and King Pharmaceuticals, Inc.
("King") announced that the proposed acquisition of King by the Company would
not be consummated. In light of this development, the Reporting Persons plan to
exit completely their position in the Shares and to terminate the security-based
swap agreements in place with respect to the Shares as the Shares are sold until
all such shares are sold. The Reporting Persons intend to effect all sale
transactions on the open market at the closing price of the Company's stock as
reported on the New York Stock Exchange on the date of the transaction. To the
extent practicable, shares will be sold daily until the entire position is sold.
The Reporting Persons reserve the right to purchase or sell the
Shares or other shares of Common Stock and to add to or reduce any hedging
positions they may have established in respect of the Shares or any other shares
of Common Stock. The Reporting Persons reserve the right to change their plans
or intentions and to take any and all actions that they may deem appropriate to
maximize the value of their investment in the Company in light of their general
investment policies, market conditions, subsequent developments affecting the
Company and the general business and future prospects of the Company.
Except as otherwise described herein, none of the Reporting Persons
has any current plans or proposals that relate to or would result in any of the
transactions or changes contemplated in Items 4(a) through 4(j) of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER:
(a)-(b) Perry Corp. is the indirect beneficial owner of 26,626,300
shares of Common Stock, which constitutes approximately 9.89% of the Issuer's
outstanding shares of Common Stock, based upon 269,242,000 shares of Common
Stock outstanding as of February 3, 2005. Perry Corp. has sole power to vote and
sole power to dispose of the Common Stock. By virtue of his position as
President and sole stockholder of Perry Corp., Richard C. Perry may be
considered to indirectly beneficially own such shares. Richard C. Perry
disclaims any beneficial ownership interest of the Common Stock held by any
funds for which Perry Corp. acts as the general partner and/or investment
adviser, except for that portion of such Common Stock that relates to his
economic interest in such Common Stock.
(c) None.
-4-
(d) The limited partners of (or investors in) each of two or more
private investment funds for which Perry Corp. acts as general partner and/or
investment adviser have the right to participate in the receipt of dividends
from, or proceeds from the sale of, the shares held for the accounts of their
respective funds in accordance with their respective limited partnership
interests (or investment percentages) in their respective funds.
(e) Not Applicable.
-5-
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
PERRY CORP.
Dated: March 18, 2005
New York, New York By: /s/ Richard C. Perry
-----------------------------------
Name: Richard C Perry
Title: President
Dated: March 18, 2005
New York, New York /s/ Richard C. Perry
-----------------------------------
Richard C Perry
-6-